Published on 11/4/2023 in the Prospect News Structured Products Daily.
New Issue: UBS prices $137,757 12.15% trigger yield optimization notes on Moderna
By Kiku Steinfeld
Chicago, Nov. 6 – UBS AG, London Branch priced $137,757.51 of 12.15% trigger yield optimization notes due April 10, 2024 linked to the common stock of Moderna Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The face amount of each note is $154.61, which is equal to the initial share price of Moderna stock.
Interest is payable monthly.
The payout at maturity will be par unless the final price of Moderna stock is less than 60% of the initial share price, in which case investors will be exposed to the share price decline from the initial price.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger yield optimization notes
|
Underlying stock: | Moderna Inc.
|
Amount: | $137,757.51
|
Maturity: | April 10, 2024
|
Coupon: | 12.15%, payable monthly
|
Price: | Par of $154.61
|
Payout at maturity: | Par unless the final price of Moderna stock is less than 60% of the initial share price, in which case investors will be exposed to the share price decline from the initial price
|
Initial share price: | $154.61
|
Trigger price: | $92.77, 60% of initial price
|
Pricing date: | April 5, 2023
|
Settlement date: | April 10, 2023
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 2%
|
Cusip: | 90286J781
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.